Health Care: Drugs

Depomed Inc (DEPO: NASDAQ)

$24.51 n/a | n/a%
09/23/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 342.74M 390.36M 134.21M 90.82M
Cost of Sales 49.52M 8.79M 4.70M 5.17M
Gross Operating Profit 293.22M 381.57M 129.51M 85.65M
Selling, General, and Administrative Expenses 199.35M 121.13M 105.18M 97.65M
Research & Development 72.44M 7.12M 8.07M 15.46M
Operating Income before D & A (EBITDA) 21.42M 253.33M 16.26M -27.46M
Depreciation & Amortization 101.72M 16.51M 6.94M 2.89M
Interest Income 599.00K 215.00K 662.00K 520.00K
Other Income - Net 29.90M 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -49.80M 237.03M 9.98M -29.83M
Interest Expense 73.44M 23.92M 5.40M 39.00K
Pre-Tax Income -123.24M 213.11M 4.58M -29.87M
Income Taxes -47.50M 81.35M -38.73M -91.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -75.74M 131.76M 43.31M -29.78M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -75.74M 131.76M 43.31M -29.78M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -75.74M 131.76M 43.31M -29.78M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-75.74M 131.76M 43.31M -29.78M
Preferred Dividends
Net Income Available To Common -75.74M 131.76M 43.31M -29.78M
Basic EPS from Continuing Ops. -1.26 2.26 0.76 -0.53
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.26 2.26 0.76 -0.53
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.26 2.26 0.76 -0.53
Basic Normalized Net Income/Share -1.26 2.26 0.76 -0.53
EPS fr Continuing Ops. -1.26 2.05 0.75 -0.53
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.26 2.05 0.75 -0.53
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.26 2.05 0.75 -0.53
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.26 2.05 0.75 -0.53
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with DEPO

Latest DEPO Headlines from TheStreet

More Financial News for DEPO

Press Releases for DEPO

See All Press Releases

Partner Headlines for DEPO

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter